• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

Pediatric Studies Characteristics - Detail

  • Print
  • Share
  • E-mail
Approval Date:  06/24/2008
Trade Name:  KINRIX
Generic or Proper Name (*):  Diphtheria and Tetanus Toxoids and Acellular Pertussis Adsorbed and Inactivated Poliovirus Vaccine*
Indications Studied:  Active immunization against diphtheria, tetanus, pertussis, & poliomyelitis as the fifth dose in the diphtheria, tetanus, and acellular pertussis (DTaP) vaccine series and the fourth dose in the inactivated poliovirus vaccine (IPV) series when previous DTaP vaccine doses have been with INFANRIX and/or PEDIARIX and for the first three doses and INFANRIX for the fourth dose
Therapeutic Category:  Preventive Vaccine
Ages Studied:  4 - 6 years
Study #:  3
Study Type:  Safety/Immunogenicity
Study Design:  Open Label/Active Control
No Patients:  362
No Centers:  3
No Countries:  1